{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:47:53Z","timestamp":1746337673275},"reference-count":34,"publisher":"Hindawi Limited","issue":"3","license":[{"start":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T00:00:00Z","timestamp":1394064000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T00:00:00Z","timestamp":1394064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1111\/jcpt.12143","type":"journal-article","created":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T12:37:10Z","timestamp":1394109430000},"page":"314-318","source":"Crossref","is-referenced-by-count":7,"title":["Association of gene polymorphisms with the risk of warfarin bleeding complications at therapeutic INR in patients with mechanical cardiac valves"],"prefix":"10.1155","volume":"39","author":[{"given":"S. H.","family":"An","sequence":"first","affiliation":[{"name":"College of Pharmacy & Pharmaceutical Sciences; Ewha Womans University; Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. E.","family":"Lee","sequence":"additional","affiliation":[{"name":"College of Pharmacy & Pharmaceutical Sciences; Ewha Womans University; Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. C.","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Thoracic & Cardiovascular Surgery; Yonsei University Medical Center; Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. S.","family":"Gwak","sequence":"additional","affiliation":[{"name":"College of Pharmacy & Pharmaceutical Sciences; Ewha Womans University; Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2014,3,6]]},"reference":[{"issue":"3 suppl","key":"10.1111\/jcpt.12143-BIB0001|jcpt12143-cit-0001","doi-asserted-by":"crossref","first-page":"204S","DOI":"10.1378\/chest.126.3_suppl.204S","article-title":"The pharmacology and management of the vitamin K antagonists: the seventh ACCP conference on antithrombotic and thrombolytic therapy","volume":"126","author":"Ansell","year":"2004","journal-title":"Chest"},{"key":"10.1111\/jcpt.12143-BIB0002|jcpt12143-cit-0002","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1378\/chest.127.1.53","article-title":"Thromboembolic and bleeding complications following St. Jude Medical valve replacement: results of the German Experience with Low-Intensity Anticoagulation Study","volume":"127","author":"Hering","year":"2005","journal-title":"Chest"},{"key":"10.1111\/jcpt.12143-BIB0003|jcpt12143-cit-0003","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1067\/mtc.2003.53","article-title":"\u201cOur complication rates are lower than theirs\u201d: statistical critique of heart valve comparisons","volume":"125","author":"Grunkemeier","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1111\/jcpt.12143-BIB0004|jcpt12143-cit-0004","first-page":"10","article-title":"Anticoagulation in patients following prosthetic heart valve replacement","volume":"15","author":"Akhtar","year":"2009","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"10.1111\/jcpt.12143-BIB0005|jcpt12143-cit-0005","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa022913","article-title":"Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation","volume":"349","author":"Hylek","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12143-BIB0006|jcpt12143-cit-0006","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1056\/NEJM199608223350802","article-title":"An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation","volume":"335","author":"Hylek","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12143-BIB0007|jcpt12143-cit-0007","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1253\/circj.71.761","article-title":"Incidence of major bleeding complication of warfarin therapy in Japanese patients with atrial fibrillation","volume":"71","author":"Suzuki","year":"2007","journal-title":"Circ J"},{"key":"10.1111\/jcpt.12143-BIB0008|jcpt12143-cit-0008","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1182\/blood.V96.5.1816","article-title":"Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment","volume":"96","author":"Taube","year":"2000","journal-title":"Blood"},{"key":"10.1111\/jcpt.12143-BIB0009|jcpt12143-cit-0009","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1160\/TH04-02-0083","article-title":"Warfarin dosing and cytochrome P450 2C9 polymorphisms","volume":"91","author":"Joffe","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1111\/jcpt.12143-BIB0010|jcpt12143-cit-0010","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.clpt.2005.08.006","article-title":"Several-fold increase in risk of overanticoagulation by CYP2C9 mutations","volume":"78","author":"Lindh","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/jcpt.12143-BIB0011|jcpt12143-cit-0011","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.clpt.2003.09.015","article-title":"CYP2C9 genotypes and dose requirements during the induction phase of oral anticoagulant therapy","volume":"75","author":"Peyvandi","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/jcpt.12143-BIB0012|jcpt12143-cit-0012","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00008571-199710000-00004","article-title":"Genetic association between sensitivity to warfarin and expression of CYP2C9*3","volume":"7","author":"Steward","year":"1997","journal-title":"Pharmacogenetics"},{"key":"10.1111\/jcpt.12143-BIB0013|jcpt12143-cit-0013","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/sj.clpt.6100144","article-title":"Warfarin response and vitamin K epoxide reductase complex 1 in African Americans and Caucasians","volume":"81","author":"Schelleman","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/jcpt.12143-BIB0014|jcpt12143-cit-0014","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa0708078","article-title":"Genetic determinants of response to warfarin during initial anticoagulation","volume":"358","author":"Schwarz","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12143-BIB0015|jcpt12143-cit-0015","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1160\/TH07-09-0552","article-title":"An analysis of the relative effects of VKORC1 and CYP2C9 variants on anticoagulation related outcomes in warfarin-treated patients","volume":"100","author":"Meckley","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1111\/jcpt.12143-BIB0016|jcpt12143-cit-0016","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/FPC.0b013e3283317ab5","article-title":"Genetic and environmental factors determining clinical outcomes and cost of warfarin therapy: a prospective study","volume":"19","author":"Jorgensen","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"10.1111\/jcpt.12143-BIB0017|jcpt12143-cit-0017","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00228-010-0813-6","article-title":"Increased frequency of CYP2C9 variant alleles and homozygous VKORC1*2B carriers in warfarin-treated patients with excessive INR response","volume":"66","author":"Molden","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jcpt.12143-BIB0018|jcpt12143-cit-0018","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1073\/pnas.78.4.2249","article-title":"Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C","volume":"78","author":"Esmon","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jcpt.12143-BIB0019|jcpt12143-cit-0019","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/archinternmed.2009.170","article-title":"Thrombomodulin as a marker for bleeding complications during warfarin treatment","volume":"169","author":"Lind","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1111\/jcpt.12143-BIB0020|jcpt12143-cit-0020","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1161\/01.CIR.96.9.2938","article-title":"High concentration of thrombomodulin in plasma is associated with hemorrhage: a prospective study in patients receiving long-term anticoagulant treatment","volume":"96","author":"Jansson","year":"1997","journal-title":"Circulation"},{"key":"10.1111\/jcpt.12143-BIB0021|jcpt12143-cit-0021","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.surg.2005.06.003","article-title":"C-reactive protein decreases expression of thrombomodulin and endothelial protein C receptor in human endothelial cells","volume":"138","author":"Nan","year":"2005","journal-title":"Surgery"},{"key":"10.1111\/jcpt.12143-BIB0022|jcpt12143-cit-0022","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2796.2008.02015.x","article-title":"C-reactive protein and coronary heart disease: a critical review","volume":"264","author":"Casas","year":"2008","journal-title":"J Intern Med"},{"key":"10.1111\/jcpt.12143-BIB0023|jcpt12143-cit-0023","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/ije\/dyp199","article-title":"Polymorphisms of the CRP gene inhibit inflammatory response and increase susceptibility to depression: the Health in Men Study","volume":"38","author":"Almeida","year":"2009","journal-title":"Int J Epidemiol"},{"key":"10.1111\/jcpt.12143-BIB0024|jcpt12143-cit-0024","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1161\/CIRCULATIONAHA.105.591271","article-title":"Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level","volume":"113","author":"Kathiresan","year":"2006","journal-title":"Circulation"},{"key":"10.1111\/jcpt.12143-BIB0025|jcpt12143-cit-0025","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.4238\/2012.May.14.5","article-title":"Common variants in the CRP gene are associated with serum C-reactive protein levels and body mass index in healthy individuals in Mexico","volume":"11","author":"Flores-Alfrao","year":"2012","journal-title":"Genet Mol Res"},{"key":"10.1111\/jcpt.12143-BIB0026|jcpt12143-cit-0026","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials","volume":"123","author":"Mehran","year":"2012","journal-title":"Circulation"},{"key":"10.1111\/jcpt.12143-BIB0027|jcpt12143-cit-0027","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/01.ATV.0000134298.25489.92","article-title":"Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation","volume":"24","author":"Wouwer","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jcpt.12143-BIB0028|jcpt12143-cit-0028","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/ddh021","article-title":"Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus","volume":"13","author":"Russell","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1111\/jcpt.12143-BIB0029|jcpt12143-cit-0029","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1469-1809.2006.00272.x","article-title":"Influence of genetic variation in the C-reactive protein gene on the inflammatory response during and after acute coronary ischemia","volume":"70","author":"Suk Danik","year":"2006","journal-title":"Ann Hum Genet"},{"key":"10.1111\/jcpt.12143-BIB0030|jcpt12143-cit-0030","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/eurheartj\/ehl018","article-title":"C-reactive protein gene haplotypes and risk of coronary heart disease: the Rotterdam Study","volume":"27","author":"Kardys","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1111\/jcpt.12143-BIB0031|jcpt12143-cit-0031","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1529-8817.2005.00210.x","article-title":"Association of common CRP gene variants with CRP levels and cardiovascular events","volume":"69","author":"Miller","year":"2005","journal-title":"Ann Hum Genet"},{"key":"10.1111\/jcpt.12143-BIB0032|jcpt12143-cit-0032","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/jama.287.13.1690","article-title":"Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy","volume":"287","author":"Higashi","year":"2002","journal-title":"JAMA"},{"key":"10.1111\/jcpt.12143-BIB0033|jcpt12143-cit-0033","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1182\/blood-2008-04-149070","article-title":"The largest prospective warfarin-treated cohort supports genetic forecasting","volume":"113","author":"Wadelius","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jcpt.12143-BIB0034|jcpt12143-cit-0034","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/sj.clpt.6100290","article-title":"Influence of CYP2C9 and VKORC1 1173C\/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin","volume":"83","author":"Limdi","year":"2008","journal-title":"Clin Pharmacol Ther"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12143","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12143","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12143\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:05:19Z","timestamp":1671818719000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,6]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12143","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3,6]]}}}